{"id":953,"date":"2017-03-20T15:47:30","date_gmt":"2017-03-20T15:47:30","guid":{"rendered":"https:\/\/www.institut-myologie.org\/imotion\/?page_id=953&lang=en"},"modified":"2023-03-20T14:20:40","modified_gmt":"2023-03-20T12:20:40","slug":"our-vision-of-clinical-research","status":"publish","type":"page","link":"https:\/\/www.institut-myologie.org\/imotion\/our-vision-of-clinical-research\/?lang=en","title":{"rendered":"Our vision of clinical research"},"content":{"rendered":"

Clinical research at I-Motion aims to discover ways to improve the management and treatment of neuromuscular and neurological rare diseases in children. Clinical trials may involve new medicaments, new assessment and management techniques.<\/p>\n

<\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>\n

Since its opening in June 2015, I-Motion’s activity has resulted in\u00a0an increasing number of clinical trials with the cumulative participation of 350 patients.<\/p>\n

At I-Motion, about 20 clinical trials are currently ongoing or in preparation, including about ten neuromuscular diseases (Duchenne muscular dystrophy, spinal muscular atrophy, myotubular myopathy, etc.)\u00a0or neurological (mucopolysaccharidosis). This includes therapeutic trials, international natural history studies and non-therapeutic intervention studies (validation of evaluation devices).<\/p>\n

These trials, mostly international, are promoted by industrial partners, laboratories of AFM-Telethon (Genethon, Institute of Myology …) or AP-HP (Paris hospitals).<\/p>\n